These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hepatocellular carcinoma screening in NAFLD: The paradox of nearly half the cases arising in non-cirrhotic low risk patients. Machado MV Ann Hepatol; 2023; 28(3):101101. PubMed ID: 37116966 [No Abstract] [Full Text] [Related]
26. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Wong CR; Nguyen MH; Lim JK World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736 [TBL] [Abstract][Full Text] [Related]
27. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335 [TBL] [Abstract][Full Text] [Related]
28. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Degasperi E; Colombo M Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072 [TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease. Seif El Dahan K; Daher D; Singal AG Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899 [TBL] [Abstract][Full Text] [Related]
32. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. Marengo A; Jouness RI; Bugianesi E Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related]
34. Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management. Feng Z; Rong P; Wang W Hepatology; 2020 Jul; 72(1):361-362. PubMed ID: 31903611 [No Abstract] [Full Text] [Related]
35. [Research advances in the pathogenesis of non-alcoholic fatty liver disease-associated liver cancer]. Huang W; Zhang XX Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):157-160. PubMed ID: 28297806 [TBL] [Abstract][Full Text] [Related]
36. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. Pár A; Pár G Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838 [TBL] [Abstract][Full Text] [Related]
37. A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Michel M; Kalliga E; Labenz C; Straub BK; Wörns MA; Galle PR; Schattenberg JM Z Gastroenterol; 2020 Jan; 58(1):57-62. PubMed ID: 31931541 [TBL] [Abstract][Full Text] [Related]
38. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Loomba R; Lim JK; Patton H; El-Serag HB Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545 [TBL] [Abstract][Full Text] [Related]